Anatomic Congruent Prosthetic Knee Design
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03633201 |
|
Recruitment Status :
Active, not recruiting
First Posted : August 16, 2018
Last Update Posted : October 15, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Knee Osteoarthritis | Device: Cruciate Retaining Device: Medial Congruent | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 75 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Triple (Participant, Investigator, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Anatomic Congruent Prosthetic Knee Design - a Kinematic and Kinetic Comparison With a Standard Prosthetic Knee Design and the Native Knee |
| Actual Study Start Date : | July 11, 2017 |
| Actual Primary Completion Date : | July 1, 2021 |
| Estimated Study Completion Date : | July 1, 2023 |
| Arm | Intervention/treatment |
|---|---|
| Active Comparator: Cruciate Retaining |
Device: Cruciate Retaining
Zimmer Biomet's Personalized Knee system for knee osteoarthritis treatment. The standard insert.
Other Name: Persona Cruciate Retaining |
| Active Comparator: Medial Congruent |
Device: Medial Congruent
Zimmer Biomet's Personalized Knee system for knee osteoarthritis treatment. The new anatomical congruent shaped insert.
Other Name: Persona Medial Congruent |
| No Intervention: Healthy Controls |
- Kinematics - knee joint movement [ Time Frame: 1 year follow-up ]Relative movement (position in millimetres and orientation in degrees) of the knee joint.
- Articular joint contact [ Time Frame: 1 year follow-up ]Contact between femur and tibia
- Kinetic - knee joint contact force [ Time Frame: 1 year follow-up ]Internal knee forces (normal and share) of the femur and tibia
- Implant inducible micromotion [ Time Frame: 1 year follow-up ]Quantifying dynamic inducible micromotion during daily activities.
- Static implant migration [ Time Frame: 3, 12 and 24 month post operation using first operative day as baseline. ]baseline, three month after surgery and one year after surgery.
- Patient Reported Output Measure [ Time Frame: 1 year follow-up ]Measured pre- and post operation
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Informed and written consent.
- Primary knee osteoarthritis in capable men and women.
- Indication for cruciate-retaining total knee arthroplasty.
Exclusion Criteria:
- Patients who do not speak and read Danish.
- Patients who are pregnant or at risk of becoming pregnant during the project.
- Patients with active cancer and/or radiation or chemotherapy.
- Patients who are alcoholics or have some form of abuse that impede information and follow-up.
- Patients with severe psychiatric disease that might complicate compliance with follow-up.
- Patients with surgically implants in the affected leg and/or pace maker.
- Patients with greater thigh circumference then 60 cm.
- Patients cannot perform the described exercises.
- Patients with knee instability due to multiligament injury.
- Patients with conditions that severely compromise their gait other than knee osteoarthritis in the affected knee.
- Patients with severe fracture sequelae or severe malalignment at knee level.
- Patients with osteosynthesised fractures using bone graft at knee level.
- Patients with need of an augmentation and/or stem-elongation.
- Patients with metabolic bone disease.
- Patients with rheumatoid arthritis.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03633201
| Denmark | |
| University Clinic of Hand, Hip and Knee Surgery, Regional Hospital Holstebro | |
| Holstebro, Denmark, 7500 | |
| Principal Investigator: | Maiken T Stilling, maiken.stilling@clin.au.dk | University clinic for hand, hip and knee surgery, Regional Hospital Holstebro, Aarhus University |
| Responsible Party: | University of Aarhus |
| ClinicalTrials.gov Identifier: | NCT03633201 |
| Other Study ID Numbers: |
hev-knee-persona001 |
| First Posted: | August 16, 2018 Key Record Dates |
| Last Update Posted: | October 15, 2021 |
| Last Verified: | October 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Osteoarthritis Osteoarthritis, Knee Arthritis |
Joint Diseases Musculoskeletal Diseases Rheumatic Diseases |

